Acetic Acid

Acetic Acid

SCHEMBL896859

CC(=O)O.CC(=O)O.CC(=O)O.CCC(NCCN)[Si](OC)(OC)OC.[NaH].[NaH].[NaH]

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CPB2 Q96IY4 3/20 0.32
GGT1 P19440 1/20 0.32
CPB1 P15086 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL2347225 1.00 CPB2 (0.32) CPB2GGT1CPB1
Acetic Acid SCHEMBL896270 0.98 CPB2 (0.33) CPB2GGT1CPB1
Acetic Acid SCHEMBL22342078 0.98 CPB2 (0.33) CPB2GGT1CPB1
Acetic Acid SCHEMBL28616089 0.97 CPB2 (0.32) CPB2GGT1CPB1
SCHEMBL28403106 0.90
Acetic Acid SCHEMBL28382954 0.89
SCHEMBL2145475 0.88
Acetic Acid SCHEMBL1953730 0.86 CPB2 (0.32) CPB2GGT1CPB1
Acetic Acid SCHEMBL15453589 0.86 CPB2 (0.32) CPB2GGT1CPB1
Isopropyl Alcohol SCHEMBL6557543 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3137485-A1 CHELATOR MODIFIED MAGNETIC SILICA NANOPARTICLES, THEIR USE AND PREPARATION Universidade de Aveiro (PT) 2017-03-08 EP claimed
US-9309448-B2 Abrasive articles, method for their preparation and method of their use BASF SE (DE) 2016-04-12 US claimed
WO-2015166415-A1 CHELATOR MODIFIED MAGNETIC SILICA NANOPARTICLES, THEIR USE AND PREPARATION UNIVERSIDADE DE AVEIRO (PT) 2015-11-05 WO claimed
US-9134586-B2 Pigment-based ink HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2015-09-15 US claimed
US-9133034-B2 Chelating agent modified graphene oxides, methods of preparation and use JINING LEADERNANO TECH L.L.C. (CN) 2015-09-15 US claimed
EP-2539416-A1 ABRASIVE ARTICLES, METHOD FOR THEIR PREPARATION AND METHOD OF THEIR USE BASF SE (DE) 2013-01-02 EP claimed
US-20120330044-A1 CHELATING AGENT MODIFIED GRAPHENE OXIDES, METHODS OF PREPARATION AND USE MONTCLAIR STATE UNIVERSITY (US) 2012-12-27 US claimed
US-20120311935-A1 ABRASIVE ARTICLES, METHOD FOR THEIR PREPARATION AND METHOD OF THEIR USE BASF SE (DE) 2012-12-13 US claimed
US-20120081778-A1 PIGMENT-BASED INK HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2012-04-05 US claimed
WO-2011104639-A1 ABRASIVE ARTICLES, METHOD FOR THEIR PREPARATION AND METHOD OF THEIR USE BASF SE (DE) 2011-09-01 WO claimed
US-12032261-B2 Privacy films for electronic displays Hewlett-Packard Development Company, L.P . (US) 2024-07-09 US disclosed
US-20220183973-A1 CAPTURE AND RELEASE GELS FOR OPTIMIZED STORAGE (CaRGOS) FOR BIOSPECIMENS UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2022-06-16 US disclosed
EP-3850524-A1 PRIVACY FILMS FOR ELECTRONIC DISPLAYS Hewlett-Packard Development Company, L.P. (US) 2021-07-21 EP disclosed
US-20210191223-A1 PRIVACY FILMS FOR ELECTRONIC DISPLAYS HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2021-06-24 US disclosed
WO-2020210836-A1 CAPTURE AND RELEASE GELS FOR OPTIMIZED STORAGE (CARGOS) FOR BIOSPECIMENS UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2020-10-15 WO disclosed
US-20120311935-A1 ABRASIVE ARTICLES, METHOD FOR THEIR PREPARATION AND METHOD OF THEIR USE BASF SE (DE) 2012-12-13 US disclosed
US-20120267585-A1 VOLUME-LABELED NANOPARTICLES AND METHODS OF PREPARATION UT-BATTELLE, LLC (US) 2012-10-25 US disclosed
US-20120168671-A1 VOLUME-LABELED NANOPARTICLES AND METHODS OF PREPARATION UT-BATTELLE, LLC (US) 2012-07-05 US disclosed
US-20120081778-A1 PIGMENT-BASED INK HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2012-04-05 US disclosed
WO-2011104639-A1 ABRASIVE ARTICLES, METHOD FOR THEIR PREPARATION AND METHOD OF THEIR USE BASF SE (DE) 2011-09-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120330044-A1 CHELATING AGENT MODIFIED GRAPHENE OXIDES, METHODS OF PREPARATION AND USE SCO2, AOC1, AOX1 CPB2 1849/4885GGT1 78/4885CPB1 1742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.